Product Information

POTASSIUM CITRATE ER 15 MEQ TB is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.1804 per EA under NDC 62559029201. Its NADAC has been published 324 times since Jun 10, 2020.

FDA first approved this application on Jan 14, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CITRATE ER 15 MEQ TB

Potassium Citrate
$0.1804per EA

Strength

15 meq/1

NDC

62559029201

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

POTASSIUM CITRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA212779

FDA Approved

1/14/2020

TE Code

AB

On Market Since

3/16/2020

Pharmacological Classes

Acidifying Activity
Anti-coagulant
Calcium Chelating Activity
Calculi Dissolution Agent
Decreased Coagulation Factor Activity

Price Statistics

The NADAC for POTASSIUM CITRATE ER 15 MEQ TB has been published 324 times since Jun 10, 2020, and over the history we have for it it has declined 84.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1804 per EA
All-time high$1.2226 (Nov 11, 2020)
All-time low$0.1722 (Jul 17, 2024)
52-week high$0.2197
52-week low$0.1796
Median price$0.3383
Average price$0.4958
Largest weekly change+69.2% (May 17, 2023)
Weeks tracked324
Tracking sinceJun 10, 2020

Price History

1W

-0.8%

1M

-0.8%

3M

+0.0%

6M

-7.4%

1Y

-17.5%

3Y

-47.0%

5Y

-79.2%

All

-84.8%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of POTASSIUM CITRATE ER 15 MEQ TB?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CITRATE ER 15 MEQ TB, manufactured by ANI Pharmaceuticals, Inc., is $0.1804 per EA (NDC 62559029201), effective Aug 19, 2026.

How has the price of POTASSIUM CITRATE ER 15 MEQ TB changed over time?

Over the history we have for it, the NADAC for POTASSIUM CITRATE ER 15 MEQ TB has declined 84.8%. It has been tracked across 324 weekly CMS publications since Jun 10, 2020.

What are the highest and lowest recorded NADAC prices for POTASSIUM CITRATE ER 15 MEQ TB?

Since Jun 10, 2020, the NADAC for POTASSIUM CITRATE ER 15 MEQ TB has ranged from a low of $0.1722 (Jul 17, 2024) to a high of $1.2226 (Nov 11, 2020), with a median of $0.3383 per EA.

Are there cheaper alternatives to POTASSIUM CITRATE ER 15 MEQ TB?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as POTASSIUM CITRATE ER 15 MEQ TB in a comparable dosage form, but none are currently priced below it.

Who manufactures POTASSIUM CITRATE ER 15 MEQ TB?

POTASSIUM CITRATE ER 15 MEQ TB (NDC 62559029201) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.